MedTrace Logo

Chronic Resveratrol Supplementation in Healthy Humans

NCT01640197 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-10-19

Study results available
· View outcomes & findings →

Summary

The effects of chronic resveratrol supplementation have yet to be investigated in healthy humans. It is hypothesised that the effects will be different to those seen in acute supplementation. This study will look specifically at cognitive performance, cerebral blood flow, subjective sleep, mood and health, blood pressure and plasma levels of resveratrol. It is hypothesized that these measures will be affected differently by acute and chronic supplementation.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Resveratrol

Transmax (Biotivia). 500mg (1 capsule) per day for 28 days.

OTHER

Placebo

Methyl Cellulose. 1 capsule taken once daily for 28 days.

Sponsors & Collaborators

  • Biotivia Longevity Bioceuticals

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Principal Investigators

  • David O Kennedy, Professor · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01640197 on ClinicalTrials.gov